Sanford-Burnham is home to one of just seven National Cancer Institute (NCI)-designated basic cancer centers in the United States. Research in this center aims to pre-empt cancer before it develops, detect the disease at its earliest point, and eliminate its spread. Ongoing studies in the cancer center yield tangible medical benefits; the work of Sanford-Burnham scientists has led to two FDA-approved drugs and five experimental cancer therapies currently in clinical trials.
